Found 358 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) PHASE1 The main purpose of this study is to explore the sequential therapeutic eff...
Show More Location
Southwest Hospital of Third Millitary Medical University
Learn More & Join Trial
Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases PHASE1 The CATARSIS study explores the use of anti-CD19 CAR T-cell therapy as a no...
Show More Location
Fondazione Policlinico Universitario A. Gemelli IRCCS
Learn More & Join Trial
Genetically Modified T-cells in Treating Patients With Recurrent or Refractory Malignant Glioma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma PHASE2 This phase II trial tests whether mosunetuzumab and/or polatuzumab vedotin ...
Show More Location
Banner University Medical Center - Tucson
Learn More & Join Trial
Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma PHASE1 This phase I trial studies the side effects and best dose of genetically mo...
Show More Status
Active Not Recruiting
Location
City of Hope Medical Center
Learn More & Join Trial
CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma. PHASE1 This is a first-in-human trial proposed to test CD19-specific CAR-T cells w...
Show More Learn More & Join Trial
Non-Interventional Study of Puzol-cel for CD19-Positive Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia N/A Establishing real-world data of Chinese patients with CD19-positive relapse...
Show More Location
Multiple Locations
Learn More & Join Trial
CD19 CAR-T Cells for Patients With Relapse and Refractory CD19+ B-ALL. PHASE1 The purpose of this study is to infusion CD19 CAR-T cells to the patients w...
Show More Location
The First Affiliated Hospital of Henan University of Science and Technology
Learn More & Join Trial
Bispecific CD19/CD22 CAR-T for Treatment of Children and Young Adults With r/r B-ALL PHASE1 The purpose of this study is to evaluate the safety and efficiency of autol...
Show More Status
Active Not Recruiting
Location
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Learn More & Join Trial